Bill Text: IN SB0025 | 2011 | Regular Session | Amended
Bill Title: Study of pharmacy issues.
Spectrum: Partisan Bill (Republican 2-0)
Status: (Engrossed - Dead) 2011-03-28 - First reading: referred to Committee on Public Health [SB0025 Detail]
Download: Indiana-2011-SB0025-Amended.html
Citations Affected: Noncode.
Synopsis: Study of pharmacy issues. Requires the health finance
commission to study during the 2011 legislative interim the following
: (1) Whether a pharmacist should be required to notify the prescribing
physician and inform the patient if the pharmacist selects a drug other
than the brand name drug listed on an antiepileptic drug prescription;
and (2) Whether a pharmacist should be required to dispense a
prescription in a manner to allow label accessibility to an individual
who is blind.
Effective: July 1, 2011.
January 5, 2011, read first time and referred to Committee on Health and Provider
Services.
February 17, 2011, amended, reported favorably _ Do Pass.
PRINTING CODE. Amendments: Whenever an existing statute (or a section of the Indiana Constitution) is being amended, the text of the existing provision will appear in this style type, additions will appear in this style type, and deletions will appear in
Additions: Whenever a new statutory provision is being enacted (or a new constitutional provision adopted), the text of the new provision will appear in this style type. Also, the word NEW will appear in that style type in the introductory clause of each SECTION that adds a new provision to the Indiana Code or the Indiana Constitution.
Conflict reconciliation: Text in a statute in this style type or
A BILL FOR AN ACT concerning professions and occupations.
(b) During the 2011 interim, the commission shall study whether legislation should be introduced to require pharmacists to do the following:
(1) Notify the prescribing physician when the pharmacist selects a drug other than the brand name drug listed on an antiepileptic drug prescription.
(2) Dispense a prescription in a manner to allow prescription drug label information to be accessible to an individual who is blind or visually impaired.
